Fortis Healthcare Approves FY26 Audited Results & Recommends ₹1 Dividend
Fortis Healthcare's Board approved audited standalone and consolidated financial results for FY26 ending March 31, 2026, with an unmodified auditor opinion. A final dividend of ₹1 per share was recommended, pending member approval. M/s Jitender, Navneet & Co. appointed as Cost Auditor for FY27.
The approval of audited financial results and dividend recommendation are material events for shareholders. The appointment of a cost auditor is a routine compliance matter but contributes to corporate governance.
The announcement reports routine financial results and board decisions, including a dividend recommendation and auditor appointment. While positive, there are no exceptionally strong positive or negative indicators.
Fortis Healthcare Limited announced the outcome of its Board Meeting held on Friday, May 22, 2026. The Board approved the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2026. The Statutory Auditors, M/s. B S R & Co. LLP, have issued an Audit Report with an unmodified opinion on these results.
Additionally, the Board recommended a final dividend of ₹1 per equity share (10% of face value) for the financial year 2025-26. This dividend is subject to shareholder approval at the upcoming Annual General Meeting and will be paid/dispatched within 30 days of the AGM conclusion.
The company also approved the appointment of M/s Jitender, Navneet & Co., Cost Accountants, as the Cost Auditor for the Financial Year 2026-27. The Board further approved the policy of Corporate Social Responsibility.
The Board Meeting commenced at 09:35 Hours IST and concluded at 19:35 Hours IST on May 22, 2026.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.